NCT03629275: A trial that was reported late by ReNeuron Limited
This trial has reported, although it was 403 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT03629275 |
|---|---|
| Title | A Randomized, Placebo-Controlled Study of the Efficacy and Safety of Intracerebral Stem Cells (CTX0E03) in Subjects With Disability Following an Ischemic Stroke |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Aug. 31, 2018 |
| Completion date | Sept. 9, 2020 |
| Required reporting date | Sept. 9, 2021, midnight |
| Actual reporting date | Oct. 17, 2022 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 403 |